Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Funnel designs and develops software/platforms that help marketers automate their data collection for reporting and analysis.
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Better Therapeutics develops prescription software for treating cardiometabolic diseases.
Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Locus Robotics is a warehouse robotics company that manufactures autonomous mobile robots to support e-commerce.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
Oak Street Health is a network of primary care centers for adults on Medicare.
AmplifyBio is a biotechnology company that develops and advances treatments and cures for disease via cutting-edge technology and research.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
RumbleON provides an e-commerce platform that facilitates to sell, buy, trade pre-owned recreation vehicles.
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
Govini is a software company that transforms defense acquisition and national-security decision-making through data, analytics, and AI.
Hypercore provides a cloud-based platform that manages loan portfolios from origination through repayment.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Snappt provides fraud detection and income verification software for multifamily property managers.
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Carbyne is a software company that develops cloud-based mission-critical contact center solutions.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Remodel Health delivers software to assist employers in managing health benefits and transitioning to ICHRA.
Carwow is an online car marketplace that connects customers, automotive brands and car dealers.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Hercules Capital has invested in 67 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hercules Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 49 different industry categories.
Among tracked funding rounds, Dyne Therapeutics received $402.5M in a Post Ipo Equity round. Hercules Capital's total known invested capital is $9.1B.
Hercules Capital's average investment size is $117.8M across its portfolio of 67 companies.
Recent Hercules Capital portfolio additions include Funnel, Kura Oncology, Better Therapeutics, Sight Sciences, NorthSea Therapeutics. These companies were founded in 2020 or later.